Microbiome Submission Guide: What to Prepare Before You Submit

This page was reviewed on October 9, 2026 against the current Microbiome submission guidelines, supporting-information instructions, research-article guidance, and the journal's Submit your manuscript route on Springer Nature Link. Manusights interpretation below applies those public requirements to manuscript-level readiness signals: abstract claim strength, methods and control architecture, figure logic, data availability, reviewer suggestions, and the cover letter.

Evidence boundary: this page uses public BMC guidance and Manusights diagnostic patterns, not private Microbiome editorial correspondence or confidential reviewer files. Official guidance explains the upload rules; the practical value here is the manuscript-readiness interpretation: whether the abstract, methods, controls, figures, data availability statement, reviewer list, and cover letter make the paper look ready for Microbiome now.

Through our diagnostic work, we have found that editors specifically look for microbiome papers where the abstract, methods, figures, controls, data availability statement, and cover letter all support a biological, ecological, functional, or clinical consequence. In practice, the named failure pattern is not that a study used amplicon sequencing or a cohort design. It is that the manuscript asks Microbiome to accept a broad claim before the evidence chain is controlled, mechanistic, and review-ready.

Microbiome is broad in organism and setting, but selective in evidence logic. Editors are usually asking:

• is this more than a descriptive community-shift paper

• does the manuscript provide real mechanistic, functional, ecological, or clinically meaningful insight

• are the controls strong enough for a microbiome claim

• is the data package ready for review right now

That is why many routine association papers misfire here. The problem is not that the topic is out of scope. It is that the paper does not yet do enough scientific work.

Microbiome's current submission guidance is unusually explicit about front-end readiness.

The practical implication is simple: the formatting rules are ordinary, so the scientific weaknesses are what an editor sees first.

That is why authors who treat Microbiome like a convenient venue for a descriptive survey often misread the journal. Its aims and scope say it is especially interested in studies that go beyond descriptive omics surveys. If the package still needs one more functional experiment, one more validation set, or one more round of data organization, that weakness is easy to see.

Three problems account for most of the early rejections we see on Microbiome-targeted drafts. Each one is visible before upload if you read the manuscript the way an editor will.

1. The manuscript is mainly descriptive

Routine 16S community-shift papers, correlation-only human cohort studies, and taxonomic surveys without functional follow-up often look too early for this journal. Editors can usually tell within the abstract and the final figure whether the paper stops at "the community differs" or goes on to show why that difference matters biologically, functionally, ecologically, or clinically. When the strongest result is still the taxonomy plot, the paper reads as descriptive even when the underlying dataset is strong.

2. The controls are not convincing enough

Microbiome's guidance and editorial posture make clear that contamination controls, extraction controls, amplification controls, and other design safeguards matter. Weak controls weaken trust fast.

3. The data package is not ready

If the authors still need time to organize access to the supporting datasets, the paper is not yet aligned with the journal's stated submission rules.

Before submission, a Microbiome fit and readiness check can tell you whether the problem is causality, controls, or data-release readiness.

Across microbiome manuscripts targeting Microbiome, the strongest failures are visible before upload in the abstract, methods, figures, controls, data availability statement, reviewer list, and cover letter. BMC's public guidance sets ordinary formatting rules and does not lower the evidentiary standard. The manuscript still has to show why the microbiome result matters beyond a community description, why the control architecture can support the claim, and why the data package is ready for reviewer access now.

Failure pattern: Descriptive community shift without functional microbiome consequence

Across Manusights submission reviews for gut, environmental, plant, host-microbe, and clinical manuscripts targeting Microbiome, this pattern appears when the abstract makes the paper sound field-changing but the figures mainly show taxonomic shifts. The manuscript may have a clean cohort, a plausible disease or environmental context, and attractive alpha-diversity, beta-diversity, differential-abundance, or network plots.

The problem is that Microbiome is not usually the strongest venue for a paper whose conclusion stops at "the community differs." The title, abstract, introduction, and final figure need to show what changed biologically, functionally, ecologically, or clinically.

The fix belongs in the manuscript components, not just in the cover letter. The abstract should state the consequence without overstating causality. The methods should explain whether the evidence comes from 16S, shotgun metagenomics, metatranscriptomics, metabolomics, culture follow-up, gnotobiotic work, longitudinal sampling, intervention data, or a defensible computational inference.

Figures should connect community composition to functional pathways, host response, ecosystem process, phenotype, treatment response, or mechanistic validation. References should position the result against recent Microbiome papers and nearby venues such as The ISME Journal, Cell Host & Microbe, mSystems, Gut Microbes, Environmental Microbiome, or ISME Communications. If the strongest manuscript component is still the taxonomy figure, the paper may need another layer of functional evidence or a narrower venue.

Check whether your Microbiome manuscript has functional consequence beyond community shift →

Failure pattern: Control architecture cannot support the causal language

For manuscripts targeting Microbiome, this failure appears when the story is interesting but the methods and controls do not protect the claim. Microbiome studies are vulnerable to contamination, batch effects, compositional artifacts, sequencing-depth artifacts, extraction-kit effects, host or environmental confounding, and overinterpretation of correlation. A manuscript can have a persuasive biological premise and still look early if the controls are buried in supplementary files, not tied to the main figures, or not strong enough for the causal verbs used in the abstract and discussion.

The practical check is component by component. The methods should name extraction controls, negative controls, positive controls, mock communities, randomized processing, batch handling, inclusion criteria, exclusion criteria, statistical analysis, and sensitivity checks where relevant. The main figures should show that the signal survives the obvious alternative explanations, not just that it reaches statistical significance. Supplementary tables should make sample exclusions and metadata completeness auditable.

The cover letter should avoid claiming mechanism if the paper only shows association. References should include method and contamination-control literature, not only biological background. If reviewers would ask whether the signal is technical, compositional, or confounded, Microbiome editors can see that weakness before peer review.

Sometimes the right move is to add a validation cohort, functional assay, longitudinal analysis, or mechanistic experiment before choosing between Microbiome, The ISME Journal, Cell Host & Microbe, mSystems, or a disease-specific microbiome venue.

Check whether your Microbiome controls support the manuscript's causal language →

Failure pattern: Data package is not ready at submission

For manuscripts targeting Microbiome, this is the operational failure that authors underestimate because the formatting rules look routine. BMC's guidance says data supporting the research must be available at submission. A paper can be scientifically promising and still look unready if raw reads, processed feature tables, metadata, code, supplementary methods, and data-availability statements are incomplete. The data package is not an after-acceptance cleanup item for this journal.

The readiness check should start before the manuscript PDF is final. The data availability statement should point reviewers to accession numbers or stable repositories where appropriate, such as SRA, ENA, DDBJ, Qiita, MG-RAST, MetaboLights, Metabolomics Workbench, GitHub, Zenodo, or institutional repositories.

The methods should explain preprocessing, quality control, taxonomic classification, functional annotation, statistical analysis, and reproducibility choices clearly enough for a reviewer to inspect the pipeline. Supplementary files should include sample metadata, primer or library details, software versions, and analysis outputs needed to understand the figures. The cover letter should explain any access limitations, ethics constraints, human-subjects privacy limits, or embargoes instead of hiding them.

Reviewer suggestions should be credible field fits with institutional identifiers. If these components are still being assembled, Microbiome is likely to view the package as premature even if the narrative is strong.

Check whether your Microbiome data package is submission-ready →

The review tells you whether your paper passes Microbiome mechanism, control, and data-readiness checks. Manusights checks do not train on your manuscript, and paid reviews include a 60-day money-back guarantee.

Microbiome's submission guidelines point to these for a first submission:

• main manuscript file as DOC, DOCX, RTF or TeX/LaTeX (editable files are required for production)

• cover letter explaining why the manuscript should be published in Microbiome, the mechanistic, functional, ecological, or clinical depth that distinguishes it from descriptive community surveys, any issues relating to journal policies, a competing-interests declaration, and confirmation that all authors have approved the submission and that the work is not published or submitted elsewhere

• title page with the full names, institutional addresses, and email addresses of all authors, and the corresponding author indicated

• abstract of up to 350 words with separate Background, Results, and Conclusions sections (Research articles)

• "Availability of data and materials" section with live accession numbers or similar for the datasets, plus the analysis code or scripts and metadata formatted to the MIxS standard

• ethics approval and consent to participate statement (for human participants, data, or tissue, the name of the ethics committee and its reference number where appropriate; for animal studies, a statement on ethics approval; "Not applicable" otherwise)

• competing-interests declaration (reviewers and editors are similarly required to declare competing interests and can be excluded from review)

• Authors' contributions section, using author initials

• optional suggested reviewers, entered in the cover letter with institutional email addresses where possible or an ORCID or Scopus ID (falsified reviewer details lead to rejection)

• a plan for the $5,190 USD article processing charge (institutional agreement, funder, or author-paid); requests for discretionary APC waivers or discounts must be made at submission

• documentation of any large language model use in the Methods section (LLMs cannot be authors, and Springer Nature asks authors to disclose AI use)

For Microbiome submissions, the most common artifact-related issue is metagenomic submissions without raw-read deposit accessions cited inline. The journal's data policy requires that all datasets on which the conclusions rely are available to reviewers at submission and publicly available at publication, so a promise to deposit data at acceptance does not meet it.

Run a Microbiome pre-submission readiness check before clicking submit to verify the package meets the journal's mechanism-or-function-beyond-description bar.

Microbiome manuscripts move through four stages, following Springer Nature's published editorial process. The journal's own page reports a median of 24 days from submission to first decision (Springer Nature Link, read 9 October 2026) and publishes no median time to acceptance, so the stages below carry no day counts. The aims and scope say the journal is especially interested in studies that go beyond descriptive omics surveys, so community-description submissions without mechanistic or functional follow-through are a poor fit.

Stage 1: Submission intake and initial quality check

Springer Nature's initial quality check covers authorship, competing interests, ethics approval, and plagiarism. The journal's data policy also expects every dataset supporting the conclusions to be available to reviewers at submission.

Stage 2: Editor assigned and screen for suitability

After the quality check, the manuscript is assigned to a member of the Editorial Board who is an active researcher in the field, and that editor decides whether it is suitable for peer review. Microbiome's editors are organized by topic, for example gastrointestinal, environmental and agricultural, plant, and computer science and bioinformatics.

Stage 3: External peer review (single-anonymous)

Manuscripts that the editor sends out are typically evaluated by two or more experts chosen by the editor, who may consult editorial board members if necessary. Reviewers know the authors' identities, and the reports sent to authors are anonymous.

Stage 4: Decision, revision, and appeal

The editor decides whether to accept, request minor or major revisions, or reject, and after a rejection a transfer to another Springer Nature journal may be offered. Under BMC policy, authors may file one formal appeal against a rejection through the journal.